No more needles? new study tests ultrasound-based liver check for kids with rare disease

NCT ID NCT07303140

Recruiting now Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at using liver elastography, a non-invasive ultrasound-like technique, to measure liver fibrosis in children with type III glycogen storage disease (GSDIII). The goal is to see if this method can replace painful liver biopsies for monitoring disease progression. Researchers will analyze data from 30 patients aged 0 to 21 years who have already had at least one elastography measurement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that liver elastography is a reliable way to monitor liver fibrosis in children with GSDIII, reducing the need for invasive biopsies.
What could go wrong: This is an observational study with only 30 participants, so results may not apply to all patients. The technique may not be as accurate in children as in adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver fibrotic liver disease glycogen storage disease III

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER FIBROSIS

Contacts and locations

Locations

Service de pédiatrie 1 - CHU de Strasbourg - France
RECRUITING

Strasbourg, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.